Philip H. Coelho - 13 Sep 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Philip H. Coelho
Issuer symbol
CPRX
Transactions as of
13 Sep 2022
Net transactions value
-$472,000
Form type
4
Filing time
15 Sep 2022, 17:00:38 UTC
Previous filing
19 Aug 2022
Next filing
23 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale $157,000 -10,000 -3.6% $15.70 269,553 13 Sep 2022 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $315,000 -20,000 -7.4% $15.75 249,553 14 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. Coelho remains a director of the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold at prices ranging from $15.70 to $15.80 per share.